Figure 3.
Association of adipogenesis pathway score with patient survival by whole and each subtype in the GSE96058 and TCGA cohorts. Kaplan–Meier plots of Disease-specific survival (DSS) in the TCGA cohort, and overall survival (OS) in both cohorts by adipogenesis low (blue) and high (red) score with (A) whole, (B) Estrogen receptor (ER)+/HER2−, (C) human epidermal growth factor receptor 2 (HER2)-positive, or (D) Triple negative breast cancer (TNBC) patients. Median value was used as the cut-off to divide into low and high adipogenesis score groups within each cohort. P-value was calculated using log-rank test.